Report #2838371

Received Apr 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 60 yrs
State: MS
Recovered: Unknown
Vaccinated: Apr 8, 2025
Onset: Apr 8, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

3rd dose administered.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 2nd dose on 07-SEP-2022) and Shingrix (received 1st dose on an unknown date). On 08-APR-2025, the patient received the 3rd dose of Shingrix. On 08-APR-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: 3rd dose administered.). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 23-APR-2025 The pharmacist called to inform that back in 08th April 2025 somebody received an extra dose of a vaccine, such vaccine was Shingrix which led to extra dose administration. According to reporter, the Shingrix series was completed back on 07th September 2022.